Given the steatohepatitis-like features in Mof null mice (e.g., increase of fat deposition, fibrosis, elevated serum AST and ALT), we compared gene pathways dysregulated by Mof deletion with those in human NASH patients. Here, KAT8 is linked to metabolic dysfunction-associated steatohepatitis.